Startup Ideas AI

Develop a non-invasive prenatal genetic testing method to detect rare genetic disorders early in pregnancy, reducing anxiety and uncertainty. This technology can provide accurate results using a blood sample from the pregnant mother. Market size: The global non-invasive prenatal testing market was valued at $1.3 billion in 2020 and is projected to reach $4.9 billion by 2028 at a CAGR of 17.2%. Tags: genetic testing, prenatal care, rare genetic disorders, non-invasive, early detection. Country: United States, China, Germany, United Kingdom, Japan. Customer total: 500,000